Acutus Medical Closes Out Series B At $28M

San Diego-based minimally invasive, cardiac catheter developer Acutus Medical reported Tuesday that it has closed out its Series B funding at $28M. According to the company, the round was led by OrbiMed Advisors and GE Ventures, and also included existing investors Index Ventures and Advent Life Sciences. Acutus had announced the initial close of the round, which was worth $21M, back in June. According to the company, it will be using the new funding to support product development, clinical trials, regulatory approvals and early commercialization. Acutus Medical develops a cardiac catheter being used to treat irregular heart rhythms, and specifically atrial fibrillation (AF). The firm's technology revolves around real-time, 3D imaging of a patient's cardiac chamber to identify, and treat, the specific tissue responsible for the cardiac arrhythmia. More information »